These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39400356)

  • 1. Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology.
    Boon BDC; Frigerio I; de Gooijer D; Morrema THJ; Bol J; Galis-de Graaf Y; Heymans M; ; Murray ME; ; van der Lee SJ; Holstege H; van de Berg WDJ; Jonkman LE; Rozemuller AJM; Bouwman FH; Hoozemans JJM
    Neuropathol Appl Neurobiol; 2024 Oct; 50(5):e13009. PubMed ID: 39400356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
    McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease.
    Therriault J; Pascoal TA; Savard M; Benedet AL; Chamoun M; Tissot C; Lussier F; Kang MS; Thomas E; Terada T; Rej S; Massarweh G; Nasreddine Z; Vitali P; Soucy JP; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    Neurology; 2021 Jan; 96(1):e81-e92. PubMed ID: 33093220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
    Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
    Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Hart de Ruyter FJ; Evers MJAP; Morrema THJ; Dijkstra AA; den Haan J; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJ; Hoozemans JJM
    Acta Neuropathol; 2024 Aug; 148(1):24. PubMed ID: 39160362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.
    Sánchez-Juan P; Valeriano-Lorenzo E; Ruiz-González A; Pastor AB; Rodrigo Lara H; López-González F; Zea-Sevilla MA; Valentí M; Frades B; Ruiz P; Saiz L; Burgueño-García I; Calero M; Del Ser T; Rábano A
    Brain; 2024 May; 147(5):1667-1679. PubMed ID: 38634687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
    Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology of Alzheimer's Disease.
    Trejo-Lopez JA; Yachnis AT; Prokop S
    Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Behavioral/Dysexecutive Variant of Alzheimer's Disease: A Case Series with Clinical, Neuropsychological, and FDG-PET Characterization.
    Bergeron D; Sellami L; Poulin S; Verret L; Bouchard RW; Laforce R
    Dement Geriatr Cogn Disord; 2020; 49(5):518-525. PubMed ID: 33207355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminex-based quantification of Alzheimer's disease neuropathologic change in formalin-fixed post-mortem human brain tissue.
    Keene CD; Wilson AM; Kilgore MD; Bruner LT; Postupna NO; Darvas M
    Lab Invest; 2019 Jul; 99(7):1056-1067. PubMed ID: 30573871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
    Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
    Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels.
    Murray ME; Moloney CM; Kouri N; Syrjanen JA; Matchett BJ; Rothberg DM; Tranovich JF; Sirmans TNH; Wiste HJ; Boon BDC; Nguyen AT; Reichard RR; Dickson DW; Lowe VJ; Dage JL; Petersen RC; Jack CR; Knopman DS; Vemuri P; Graff-Radford J; Mielke MM
    Mol Neurodegener; 2022 Dec; 17(1):85. PubMed ID: 36575455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.
    Guo T; Li A; Sun P; He Z; Cai Y; Lan G; Liu L; Li J; Yang J; Zhu Y; Zhao R; Chen X; Shi D; Liu Z; Wang Q; Xu L; Zhou L; Ran P; Wang X; Sun K; Lu J; Han Y
    Mol Neurodegener; 2024 Jul; 19(1):58. PubMed ID: 39080744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.